In recent years, an emerging deeper understanding of the various mechanisms behind IFN’s unique effects on tumor biology has renewed interest in their application as cancer therapeutics in particular in MPN treatment. This evidence concerns the gene IFNA1 and myeloproliferative neoplasm.